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Abstract
Objectives: to obtain a biomedical oral profile of a community of adult drug addicts in treatment by analysing their den-
tal health, with a view to determining whether the state of their oral health could be attributed primarily to their lifestyle 
and the direct consequences of drug abuse on their overall condition, rather than to the effects of the drugs used. 
Experimental Design: the study was conducted under the terms of an agreement between the Complutense Uni�-
versity of Madrid’s (UCM) Odontology Faculty and the City of Madrid’s Substance Abuse Institute. Seventy drug 
addicts and 34 control group subjects were examined. The study assessed oral hygiene habits, systemic pathology, 
type of drugs used and the duration of use, oral pathology, oral health indices, risk of caries based on saliva tests, 
oral candidiasis and periodontal microbiology. 
Results: statistically significant differences (p<0.05) were found between the test and control groups for practically all 
the variables analysed. In the drug users group, dental hygiene was wanting, systemic and oral pathology prevailed and 
the decayed/missing/filled teeth or surface (DMFT/S) indices denoted very poor buccodental health. The saliva tests 
showed a substantial risk of caries and candidiasis rates were high. By contrast, with a single exception, the microbio-
logical studies detected no statistically significant difference between drug users and control groups periodontal flora.
Conclusions: drug�dependent patients had poor oral health and a significant increase in oral pathology, essentially 
caries and periodontal disease. Their risk of caries was high and the presence of candidiasis was representative 
of their poor general and oral health. Drug users’ poor buccodental condition was more closely related to lifestyle 
than to drug abuse itself.
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Introduction
In 1992, the WHO defined drug addiction as “a state, 
psychic and sometimes also physical, resulting in the in-
teraction between a living organism and a drug, charac-
terized by behavioural and other responses that always 
include a compulsion to take the drug on a continuous 
or periodic basis in order to experience its psychic ef-
fects, and sometimes to avoid the discomfort of its ab-
sence. Tolerance  may or may not be present.”
Some of the most prominent conclusions on substance 
abuse trends and problems in Spain in recent years in-
clude the following. Tobacco use, observed to decline 
through 2007, has since flattened; the proportion of al-
cohol users is steady or declining, although the rate of 
intensive consumption episodes is rising; the number of 
intravenous drug users receiving treatment is no longer 
contracting; mortality directly related to illegal drugs is 
gradually falling; high HIV and hepatitis infection rates 
persist in I/V drug users, along with risky sex and injec-
tion behaviour, although the number of new HIV diag-
noses has dropped steeply; heroin use may be flatten-
ing or even rising after many years of decline; cocaine 
and cannabis use has stabilised or may have begun to 
slide; hypnosedative drug use is rising, while the use 
and abuse of ecstasy, amphetamines and hallucinogens 
continues to fall. 
Very little research today addresses drug users’ oral 
health, among other reasons because of the difficulty in-
herent in monitoring and tracking the subjects (1,2). One 
pioneer study noted that drug users tend to suffer from 
anxiety in connection with dental treatment and report 
difficulties in accessing such care, or even reluctance 
among some dentists (as well as other health care pro-
fessionals) to treat them (3,4). As their pain tolerance is 
generally low, relief must be administered carefully and 
good rapport with the dentist established (5). As a rule 
they are scantly motivated to abide by oral health stand-
ards or guidelines, or to follow treatment recommenda-
tions. Dentists should be alert to and able to identify 
drug abuse�related oral problems (6) to furnish suitable 
information and care (4). Dental treatment needs to be 
systematically included in the comprehensive treatment 
afforded drug users (7�10). Moreover, the treatment plan 
should be personalised (11). An accurate stomatological 
assessment is a must for these patients, who need in-
creasingly frequent dental care (12). The present study 
was conducted in the context of the dental care provided 
as one of a series of measures to further social reinser-
tion. Implicit in this action was the recognition of the 
importance of psychological balance, which is largely 
dependent on physical appearance and quality of oral 
life. In this high dental risk community, care calls for 
close collaboration between social work and health care 
professionals (13,14).
Material and Methods
1. Material. Reference population and sampling
A retrospective cohort study was conducted under an 
agreement between the Complutense University of 
Madrid’s Odontology Faculty and the City of Madrid’s 
Health Substance Abuse Institute. A total of 70 drug 
addicts in treatment, ranging in age from 30 to 56, were 
assessed. Prior to the study, a referral report was re-
ceived from the Substance Abuse Institute’s Drug User 
Assistance Centres (Spanish initials, CAD) or Proyecto 
Hombre, an NGO engaging in drug addition treatment 
and prevention. All the patients were institutionalised 
in these centres, from which they were referred to the 
Odontology Faculty for comprehensive, cost�free den-
tal treatment (funded by the Substance Abuse Institute). 
Buccodental health was also analysed in a control group 
of 34 patients, ranging in age from 30 to 59. 
The patients were informed of their state of oral health, 
the objectives of the study and the methods to be used. 
All voluntarily agreed to participate in the study and 
signed an informed consent form. All the examinations 
were conducted by just two dentists. The Kappa intra� 
and inter�observer diagnostic concurrence values for 
the oral examinations were never lower than 0.60, i.e., 
within the suitability range.
2. Method
Patients were examined and treated as part of the un-
dergraduate course entitled Integrated Adult Clinical 
Dentistry (Stomatology I Department). 
2.1. Clinical history: referring facility, reason for the 
consultation, health questionnaire, drug use history 
(type of drug used, year of initiation, habituation and 
discontinuation, administration method, frequency of 
use in the last year and month), dental history (anxi-
ety around dental treatment, possible allergy to dental 
anaesthesia, oral hygiene habits and the existence in the 
past or present of mouth burn, ulcers, foul taste, hali-
tosis, retching, gum bleeding or dry mouth) and lastly, 
family background.
2.2. Examination: soft tissue (general, locoregional and 
buccal), dental and periodontal.
Each substance user’s most frequent pathologies were 
recorded on the grounds of the definitions in the scien-
tific literature: rampant caries, root caries, oral mucosi-
tis, angular cheilitis, candidiasis, herpes, ulceration, 
pappose leukoplakia, gingivitis, periodontitis, papil-
loma, oral pain and xerostomia. 
 Oral health indices were also determined to evalu-
ate the prevalence of caries (DMFT, DMFS and Katz 
root caries indices) and periodontal disease (Conroy 
and Sturzenberger severity of surface dental calculus 
(CSSI), bleeding or gingival index and the O’Leary 
plaque index).
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2.3. Supplementary trials:
a) Photographs.
b) Orthopantomography.
c) Biopsy: only where suspected and in the absence of a 
clinical diagnosis of the damage observed.
d) Saliva tests:
d.1. Determination of volume: measured after stimula-
tion (normal stimulated salivary flow = 1�2 ml/min).
d.2. Determination of salivary pH: measured in the Od-
ontology Faculty laboratory with a Crison® micropH 
2001 pH�meter (normal pH may range from 5.6 to 7.6 
(~6.75).
d.3. Determination of buffer capacity: using the CRT® 
buffer test.
d.4. Streptococcus and Lactobacillus count: measured 
with the CRT® bacteria technique.
e) Detection of specific bacteria in periodontal pockets: 
the deepest pocket areas in each quadrant of the buccal 
cavity were located and samples were taken in four wher-
ever possible, inserting two number 30 sterile paper tips 
per periodontal pocket. The samples were analysed for 
the following microorganisms: Aggregatibacter actino-
mycetemcomitans, Porfiromona gingivalis, Prevotella 
intermedia, Micromonas micros, Eikenella corrodens, 
Fusobacterium nucleatum, Tannerella forsythia, Campy-
lobacter rectus, Capnocytophaga spp, Eubacterium spp. 
f) Dorsal lingual and jugal mucous membrane smears: 
taken with sterile cotton swabs and analysed in the lab-
oratory for Candida spp. 
2. 4. Statistical analysis: the data were analysed with 
IBM SPSS Statistics 19.0® software. The first phase of 
the statistical study consisted of a descriptive analysis 
of all the variables. That was followed by a compari-
son of the continuous variables in terms of a categorical 
variable for the two groups of populations (drug addicts 
vs control). The statistical tests applied to determine the 
existence of significant differences between the control 
and experimental groups were Student’s t�test (com-
parison of two means, assuming equal variance and 
normal distributions) and the Welch�adjusted Student’s 
t�tests (for unequal variance). Two categorical vari-
ables were also compared (in per cent) and the p values 
were obtained with either the Pearson’s chi�square or 
a likelihood ratio test. Lastly, contingency tables and 
independence tests (such as chi�square or Fisher) were 
used to assess the effect of certain variables on the drug 
user group, along with means, standard deviations and 
comparison of means (with ANOVA or Student’s t). The 
value adopted for statistical significance was 0.05.
Results
The total number of subjects in this group was reduced 
to 64 poly�drug users, after six alcohol users only were 
excluded.
Most (89.1%) of these patients had low and the rest 
(10.9%) medium social�cultural backgrounds. None 
were from a high social�cultural background.
For 32.8% (n=21), the primary reason for seeking care 
was to re�establish buccodental function, while 31.3% 
(n=20) were concerned about their health and 29.7% 
(n=19) about their appearance. Only 6.3% (n=4) of the 
patients presented with pain. While the drug�dependent 
patients were more interested in recovering their buc-
codental function, the control group showed a greater 
interest in their general health. This difference was sta-
tistically significant (p<0.001).
Oral hygiene habits were deficient in 64.1% (n=41) of 
drug users, who said they never brushed their teeth; 
17.2% (n=11) brushed once a day and 18.8% (n=12) twice 
or more. In this same group, 67.2% (n=43) reported that 
they used a mouthwash. Statistically significant differ-
ences were found between the two groups: most of the 
control group brushed their teeth more than twice daily 
(p<0,001) and were more frequent users of supplemen-
tary oral hygiene methods such as interdental (p 0.047) 
or electric (p 0.002) toothbrushes.
The systemic pathology in the experimental group 
was HCV in 76.6% (n=49), followed by HBV in 62.5% 
(n=40) and tuberculosis (or contact with tuberculosis) 
in 54.7% (n=35). HIV infection was present in 39.1% 
(n=25). Respiratory problems were also common, af-
fecting 37.5% (n=24) of the patients. Traumatism and 
gastric disorders were likewise prevalent (35.9% and 
31.3%, respectively). Overall, 29.7% of the patients had 
psychiatric/psychological pathologies, and 21.9% (n=14) 
had a sexually transmitted disease. The experimental 
group had higher rates of tuberculosis (p<0.001), hepa-
titis C (p<0.001), hepatitis B (p<0.001), HIV (p<0.001), 
sexually transmitted disease (p 0.016) and psychiatric 
disorders (p 0.022) than the control group. The inci-
dence of orofacial traumatism was also higher in the 
former (p 0.016). 
A total of 26.6% (n=17) of the experimental group was 
on antiretroviral medication, 57.8% (n=37) took psychi-
atric drugs, 17.2% (n=11) medicine for ulcers, 6.3% (n=4) 
vitamin supplements and 20.3% (n=13) were medicated 
for other disorders such as epilepsy or chronic alcohol-
ism. Differences were unsurprisingly found between 
the two groups: consumption of anti�HIV (p<0.001), 
psychiatric (p<0.001) and other types of medication 
(p<0.01) was higher among the drug addicts.
Heroin and cocaine were consumed by 96.8% and 90.6% 
of the members of this group, respectively, and were 
the drugs most commonly used, together with tobacco 
(98.4%). Methadone was consumed by 92.18% (n=59), at 
doses ranging from 5 to 150 mg/day. Alcohol was con-
sumed chronically by 53.1% (n=34), benzodiazepine by 
32.8% (n=21) and cannabis by 65.6% (n=42). The heroin 
addicts had been using the drug for 8 to 30 years, while 
the patients dependent on cocaine had been users for 6 
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to 30 years. The ranges for cannabis and tobacco were 
8 to 29 and 17 to 40 years, respectively. Alcohol was 
consumed sporadically by 4.69% (n=3). The duration of 
use was longer in the drug user group than in the control 
group for the only two drugs consumed by the latter, 
tobacco and cannabis (sporadically) (p<0.001). 
Xerostomia was perceived by 64.1% (n=41) of the user 
patients. Retching, halitosis and gum bleeding were 
reported by 35.9% (n=23), foul taste by 42.2% (n=27) 
and oral pain by 62.5% (n=40). Five patients, or 7.8%, 
claimed to have mouth ulcers (Fig. 1) and the same pro-
portion mouth burn. Dental treatment inspired anxi-
ety in nearly half of the patients (45.3%, n=29). With 
the exception of gum bleeding, which at 64.7% (n=22) 
was higher in the control group, all these symptoms 
were more accentuated in the drug�dependent group (p 
0.007).
No significant differences were observed between the 
two groups in connection with adenopathies, although 
they were more frequent among the experimental group 
(n=17).
The prevailing oral pathology among drug users was 
periodontitis, with 81.3% (n=52). Half of the patients 
presented with rampant caries (Fig. 2). At the time of 
the examination, seven (10.9%) were found to have 
angular cheilitis. Six (9.4%) had ulcers on the mucous 
membrane of the oral cavity. Leukoplakia and mucosi-
tis were diagnosed in only three patients (4.8%), while 
herpes was present in only two. Lastly, only one patient 
(1.6%) had gingivitis and papilloma. Discrepancies be-
tween the two groups were found for rampant caries 
only, whose incidence was higher among the addicts 
(p<0.001). Among the periodontal disorders, gingivitis 
was more common in the control group (p<0.001) and 
periodontitis in substance users (p<0.001) (Table 1).
The DMFT index in the test group was 22.7 (n=60) and 
the DMFS index 91.1 (n=60). The four toothless patients 
were excluded from these calculations. The mean indi-
ces for decayed (D), missing (M) and filled (F) teeth 
were 10.1, 12.1 and 0.7, respectively. The root caries in-
dex (RCI) was 23.9% on average. The means for the 
plaque (PLAQUE I.) and gingival (GINGIVAL I.) in-
dices were 74% (n=53) and 56.8% (n=54), respectively. 
The mean calculus index (CALCULUS I.) was 15.8. 
Statistically significant differences were found between 
the two groups in all the indices (p<0.001), with con-
sistently higher values in the test group. The percentage 
of decayed and missing teeth was also higher among 
the drug users (p<0.001), while the control group had a 
higher proportion of filled teeth (p<0.001). The calculus 
index was the sole measure in which the two groups had 
similar scores (p 0.992) (Table 2).
The smears revealed the presence of candida in 78.12% 
(n=50) of the addict patients, a rate significantly higher 
than found in the control group (p 0.027).
In the experimental group, the mean stimulated salivary 
secretion was 4 ml/5 minutes (n=64) (not significantly 
different from the control, p 0.967). The mean pH in the 
former, 6.8 (n=58), was slightly slower than for the latter 
(p<0.01). The buffer capacity was high in 32.8% (n=21) 
of the user patients, medium in 23.4% (n=15) and low in 
43.8% (n=28). Differences were also identified between 
the two groups with respect to this variable (p<0.001): 
while low capacity prevailed among the substance us-
ers, half of the control group members exhibited high 
capacity. According to the microbiological findings, 
67.3% (n=37) of the users`  salivary samples contained 
over 105 CFU/ml (colony�forming units per millilitre) 
of Streptococcus mutans, while 81.4% (n=48) contained 
over 105 CFU/ml of Lactobacillus. The presence of both 
S. mutans (p 0.044) and Lactobacillus (p<0.001) was 
higher in the drug addicts group (Table 3).
The mean values for the number of patients with peri-
odontal microorganisms are listed in table 4, which 
shows that F. nucleatum, the most prevalent pathogen, 
was found in 47 of the patients analysed. No statisti-
cally significant differences were observed between the 
two groups in connection with periodontal pathogens, 
with the exception of higher rates of Eubacterium spp 
in the control group (p<0.001) and the higher bacterial 
load in the test group (p 0.027). The mean number of 
microorganisms detected in each patient, i.e., the total 
periodontal flora (CFU) was 8 076 568.627 among ad-
dicts and 3 079 676.471 in the control group.
Fig. 1. Mouth ulcer.
Fig. 2. Rampant caries. 
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Discussion
The effects of illegal drug abuse on buccal health has 
been scantly researched due to the difficulty in marshal-
ling drug�dependent patients. Like the authors of the 
present study, researchers normally analyse patients in 
drug rehabilitation centres (15). As a rule, these patients 
only visit a dentist to solve an incidental problem arising 
at any given time, but once they have received emergency 
care, they are unlikely to take the professional advice giv-
en or keep follow�up appointments. In the present study, 
what patients wanted above all was to improve their oral 
health and hence their overall quality of life.
The present findings respecting poor oral health habits 
among drug addict patients, attributable essentially to 
their scant dental health education and low self�esteem, 
were consistent with earlier reports (16). When using, 
these patients needed to obtain drugs to avoid painful 
withdrawal symptoms. Personal hygiene was neither 
necessary nor important under those circumstances. In 
a very prominent article in the scientific literature on 
drug use, Scheutz proved that when methadone is ad-
ministered during habit�breaking periods, oral hygiene 
improves considerably (1). The symptoms of caries may 
on occasion be masked by drugs, except during with-
Drug Addicts Control Total P-value
 RAMPANT 
CARIES 
Absence 32 (50.0%) 33 (97.1%) 65 (66.3%) <.001 
Presence 32 (50.0%) 1 (2.9%) 33 (33.7%) 
ORAL
MUCOSITIS 
Absence 60 (95.2%) 
34
(100.0%) 
94 (96.9%) 0.550 
Presence 3 (4.8%) 0 (0.0%) 3 (3.1%) 
ANGULAR
CHEILITIS
Absence 57 (89.1%) 
34
(100.0%) 
91 (92.9%) 0.092 
Presence 7 (10.9%) 0 (0.0%) 7 (7.1%) 
HERPES
Absence 62 (96.9%) 30 (88.2%) 92 (93.9%) 0.178 
Presence 2 (3.1%) 4 (11.8%) 6 (6.1%) 
PAPILLOMA
Absence 63 (98.4%) 
34
(100.0%) 
97 (99.0%) 1.000 
Presence 1 (1.6%) 0 (0.0%) 1 (1.0%) 
ULCERATION 
Absence 58 (90.6%) 
34
(100.0%) 
92 (93.9%) 0.089 
Presence 6 (9.4%) 0 (0.0%) 6 (6.1%) 
LEUKOPLAKIA
Absence 60 (95.2%) 
34
(100.0%) 
94 (96.9%) 0.550 
Presence 3 (4.8%) 0 (0.0%) 3 (3.1%) 
GINGIVITIS 
Absence 63 (98.4%) 23 (67.6%) 86 (87.8%) <.001 
Presence 1 (1.6%) 11 (32.4%) 12 (12.2%) 
PERIODONTITIS
Absence 12 (18.8%) 23 (67.6%) 35 (35.7%) <.001 
Presence 52 (81.3%) 11 (32.4%) 63 (64.3%) 
Table 1. Comparative: Oral pathology. Drug Addicts vs Control.
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INDEX DGA Control Total P-value INDEX DGA Control Total P-value
DMFT RCI 
N 60 34 94 <.001 N 52 34 86 <.001 
Mean 22.7 11.6 18.7 Mean 23.9 3.6 15.9 
Std Dev 6 5.8 8 Std Dev 28.7 7.9 24.9 
D PLAQUE I 
N 60 34 94 <.001 N 53 34 87 0.003 
Mean 10.1 3.3 7.6 Mean 74 57.8 67.7 
Std Dev 6.6 4 6.6 Std Dev 26.3 20 25.2 
M GINGIVAL I 
N 60 34 94 <.001 N 54 34 88 <.001 
Mean 12.1 2.6 8.6 Mean 56.8 35.5 48.6 
Std Dev 7.6 2.5 7.7 Std Dev 30.5 18.8 28.5 
F CALCULUS I 
N 60 34 94 <.001 N 51 34 85 0.992 
Mean 0.7 5.9 2.6 Mean 15.8 15.9 15.8 
Std Dev 2.5 4.6 4.2 Std Dev 15.4 12.2 14.2 
DMFS
N 60 34 94 <.001 
Mean 91.1 32.7 70
Std Dev 30 20.2 38.9 
DGA Control Total P-value
SALIVARY FLOW 5 MINUTES 
N 64 34 98 0.967 
Mean 4 4 4
Std Dev 2.9 2 2.6 
pH
N 58 32 90 <.001 
Mean 6.8 7.3 7
Std Dev 0.6 0.3 0.5 
BUFFER CAPACITY 
Low 28 (43.8%) 3 (8.8%) 31 (31.6%) <.001 
Medium 15 (23.4%) 14 (41.2%) 29 (29.6%) 
High 21 (32.8%) 17 (50.0%) 38 (38.8%) 
S. mutans 
Lower than 105 CFU/ml 18 (32.7%) 18 (54.5%) 36 (40.9%) 0.044 
Higher than 105 CFU/ml 37 (67.3%) 15 (45.5%) 52 (59.1%) 
Lactobacillus 
Lower than 105 CFU/ml 11 (18.6%) 21 (63.6%) 32 (34.8%) <.001 
Higher than 105 CFU/ml 48 (81.4%) 12 (36.4%) 60 (65.2%) 
DGA: drug addicts, N: number of subjects, Std Dev: standard deviation, CFU/ml (Colony Forming 
Units/milliliter).
Table 3. Comparative: Saliva tests. Drug addicts vs Control.
DMFT: decayed/missing/fi lled teeth, DMFS: decayed/missing/fi lled surface, DGA: drug addicts, N: number of subjects, Std Dev: stan�-
dard deviation.
Table 2. Comparative: Oral health indices. Drug addicts vs Control.
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drawal or when an addict is on methadone, which is a 
weaker pain killer than heroin (16,17).
The present study found that patients with poor oral 
hygiene had higher caries indices. Moreover, the fact 
that they had filled teeth denoted a greater interest in 
their dental health. This is significant, for despite all the 
problems deriving from drug addiction, if these indi-
viduals are persistent in their good dental health hab-
its, their oral cavity will remain healthy. It shows that 
lifestyle and healthy habits are essential in preventing 
buccodental pathologies in these patients.  
One of the most severe consequences of drug addic-
tion is the appearance of deleterious systemic disease 
which, together with the associated medication, has a 
heavy impact on buccal health (18). HIV infection also 
affects the oral cavity (19), while methadone induces 
xerostomia and its high sugar content raises the risk of 
caries (20).  
The present observations on the type of drugs used con-
cur with other reports on poly�drug addiction (10). Poly�
drug use by all the patients is a problem frequently en-
countered in research on addiction, and, consequently, 
is very difficult to study the individual effect of a given 
drug in such a scenario (21). 
The present study also concurs with the literature in 
that patients identify a given oral pathology over the 
rest. Even so, patients thought that methadone was the 
primary cause of their oral deterioration (16). 
The damage most frequently found in the scientific 
literature was as follows: reddened oral mucous mem-
brane (only three, an insignificant number, of the pa-
tients in this study presented with mucositis) and pap-
pose tongue (no case was found here). One paper (22) 
reported 6.6% leukoplakia, a percentage slightly higher 
than in the present study (4.8%). Studies have been con-
ducted on the impact of each drug separately on the 
oral cavity, such as the necrotising effect of cocaine on 
the oral mucous membrane and the consequential ap-
pearance of oronasal communication due to ischemic 
necrosis of the palate (23). Substance addict patients 
have a significantly high rate of infection�related oral 
problems due largely to immunodeficiency (24). In the 
present study, the periodontal problems detected were 
in an advanced stage and half of the patients exhibited 
rampant caries. Most scientific papers focus primarily 
on these two pathologies and report findings that concur 
with the present results. One example can be found in 
Dedi c´ (9).
The oral health indices found here were compared to 
the results of an Italian study on poly�drug users (13). 
There, the DMFT index was 12.9, lower than the present 
value. In the Italian study, the breakdown of the DMFT 
Microorganisms DGA Control Total P-value Microorganisms DGA Control Total P-value
A.a. C.r. 
N 3 1 4 N 6 2 8
Mean 4.3 18.6 7.9 Mean 1.1 13.8 4.3 
Std Dev 6.7 9 Std Dev 1.2 13 7.7 
P.g. F.n. 
N 27 16 43 0.078 N 47 32 79 0.172 
Mean 13.8 24.2 17.7 Mean 7.2 4.8 6.3 
Std Dev 16.1 21.2 18.6 Std Dev 9.4 4.1 7.7 
P.i. E.c.
N 44 32 76 0.765 N 9 6 15 0.946 
Mean 5.7 6.2 5.9 Mean 1.6 1.5 1.5 
Std Dev 7.2 8.9 7.9 Std Dev 2.6 1.6 2.2 
T.f. Capn. 
N 7 4 11 N 5 2 7
Mean 2 2 2 Mean 1 0.6 0.9 
Std Dev 1.2 3.1 1.9 Std Dev 1 0.2 0.9 
M.m. Eub. 
N 21 16 37 0.592 N 9 26 35 <.001 
Mean 4.5 6 5.2 Mean 3.3 22.3 17.4 
Std Dev 5.8 10.8 8.2 Std Dev 2.8 10 12.1 
DGA: drug addicts, N: number of subjects, Std Dev: standard deviation, Aggregatibacter actinomycetemcomitans (A.a.), Porfiromona gingi-
valis (P.g.), Prevotella intermedia (P.i.), Micromonas micros (M.m.), Eikenella corrodens (E.c.), Fusobacterium nucleatum (F.n.), Tannerella 
forsythia (T.f.), Campylobacter rectus (C.r.), Capnocytophaga spp (Capn.), Eubacterium sp (Eub.). 
Table 4. Comparative: Periodontal microbiology. Drug addicts vs Control.
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components showed that caries accounted for most of 
the index, denoting a pressing need for treatment. As in 
the present study, only a small fraction of teeth had fill-
ings, an indication of the lack of patient interest in their 
oral health and a prevalence of extraction as the treat-
ment of choice. Many other authors have drawn that 
same conclusion (25). The literature contains very few 
references to the DMFS index (1,25). Caries are often 
positioned in the cervical region, frequently involving 
the root surface. In early research on addiction, that po-
sition was in fact described as a pathognomonic symp-
tom of the abuse of certain drugs (26). Quantification 
of root caries, for which no measure was found in the 
literature, is an area in need of further research.
Like the present study, the literature consistently reports 
high plaque, gingivitis and bleeding indices among 
drug addicts (1,27). The figures on gum bleeding are 
more scattered, or in some cases fail to specify whether 
bleeding was spontaneous or subsequent to periodontal 
probing. In previous studies, such as by Du et al. (27), 
the presence or absence of calculus was mentioned, but 
with no information on amount or position.  
The present results on the risk of caries and periodon-
tal disease in drug�dependent patients could not be 
compared to previous findings. Not a single study was 
found that systematically measured salivary flow, pH or 
the buffer capacity of saliva (although references were 
found to the xerostomising effect of medication, HIV 
patients, and based simply on patient perception of dry 
mouth) (26,28) or conducted tests to determine the pres-
ence of cariogenic microorganisms, such as Streptococ-
cus mutans and Lactobacillus (here Lactobacillus con-
centration was found to be significantly higher in the 
drug addict group, denoting much more intense caries 
activity.) Much the same is true of the determination of 
periodontal flora (studied only in HIV patients, addicted 
in some cases to drugs administered parenterally) (29). 
The present findings are consistent with other reports to 
the effect that a series of factors stemming from drug 
addiction are associated with high Candida levels in the 
body (30).  
The conclusion that can be drawn from the foregoing 
is that drug users in treatment had a significantly high 
rate of oral pathology, essentially caries and periodontal 
disease. Their risk of caries was high and the presence 
of candidiasis was representative of these patients’ poor 
general and oral health. Drug abuse for long periods of 
time and their local and systemic effects are only one 
of the many factors that cause this group’s oral prob-
lems. The combination of systemic immunodeficiency, 
severe organic pathology and associated medication, 
and a series of social factors such as unemployment and 
social exclusion, may be regarded as direct causes of 
the deterioration of oral health. In addition, a cariogenic 
diet, scant oral hygiene, low self�esteem and little or no 
perception of health issues, not to mention very limited 
accessibility to dental services, also contribute to the 
development of oral pathologies. Drug addiction and 
concomitant psychic deterioration induce neglect of 
oral hygiene, which is the primary cause of deleterious 
changes in the oral cavity. The present study shows that 
this community of patients needs special dental care 
and that dentists play a key role in drug use prevention 
and control. Policies that enhance access by drug ad-
dicts and other marginal groups to dental services are 
much needed.
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